Related Experiment Video
Updated: Mar 7, 2026
Matrix-assisted Autologous Chondrocyte Transplantation for Remodeling and Repair of Chondral Defects in a Rabbit Model
Published on: May 21, 2013
Current Care and Investigational Therapies in Achondroplasia
Sheila Unger1, Luisa Bonafé2, Elvire Gouze3
1Service of Genetic Medicine, Lausanne University Hospital (CHUV), Av. Pierre-Decker 2, 1011, Lausanne, Switzerland.
Insights
This review evaluates achondroplasia management, focusing on orthopedic, neurologic, and respiratory issues. Emerging therapies aim to restore bone growth and prevent severe complications in this common skeletal dysplasia.
Area of Science:
- Medical Genetics
- Orthopedics
- Pediatrics
Background:
- Achondroplasia is the most frequent non-lethal skeletal dysplasia, characterized by short stature and severe complications.
- Current care standardization attempts for achondroplasia lack consensus, partly due to insufficient data on infant mortality and surgical indications.
Purpose of the Study:
- To review current management strategies for achondroplasia.
- To identify orthopedic, neurologic, and respiratory complications and their treatments.
- To explore innovative therapies for bone growth restoration and complication prevention.
Main Methods:
- Literature review of achondroplasia management options.
- Analysis of current therapeutic approaches for associated complications.
- Evaluation of emerging and repositioned drug therapies.
Main Results:
- Management of achondroplasia complications remains challenging due to lack of standardized protocols.
- Data gaps exist regarding sudden unexplained death in infants and the efficacy of foramen magnum decompression.
- Investigational therapies show promise for improving bone growth and mitigating disease severity.
Conclusions:
- A comprehensive approach is needed to manage achondroplasia and its complications.
- Further research is crucial to establish evidence-based guidelines and optimize treatment outcomes.
- Novel therapeutic strategies offer potential for significant advancements in achondroplasia care.
Purpose Of Review:
The goal of this review is to evaluate the management options for achondroplasia, the most common non-lethal skeletal dysplasia. This disease is characterized by short stature and a variety of complications, some of which can be quite severe.
Recent Findings:
Despite several attempts to standardize care, there is still no widely accepted consensus. This is in part due to absence of concrete data on the incidence of sudden unexplained death in infants with achondroplasia and the best investigation for ascertaining which individuals could benefit from foramen magnum decompression surgery. In this review, we identify the different options of care and management for the various orthopedic, neurologic, and respiratory complications. In parallel, several innovative or drug repositioning therapies are being investigated that would restore bone growth but may also prevent complications. Achondroplasia is the most common non-lethal skeletal dysplasia. It is characterized by short stature and a variety of complications, some of which can be quite severe. Despite several attempts to standardize care, there is still no widely accepted consensus. This is in part due to absence of concrete data on the incidence of sudden unexplained death in infants with achondroplasia and the best investigation for ascertaining which individuals could benefit from foramen magnum decompression surgery. In this review, we identify the different options of care and management for the various orthopedic, neurologic, and respiratory complications. In parallel, several innovative or drug repositioning therapies are being investigated that would restore bone growth but may also prevent complications.
More Related Videos
11:22Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots
Published on: May 21, 2013
06:53A Rat Tibial Growth Plate Injury Model to Characterize Repair Mechanisms and Evaluate Growth Plate Regeneration Strategies
Published on: July 4, 2017
Related Concept Videos
01:16Clinical Trials
There are four phases in a clinical trial. A phase one...
01:27Peripheral Artery Disease III: Interprofessional Care